Environmental Toxin Illness
Toxin exposure is one of the most underdiagnosed contributors to chronic illness. Mold mycotoxins, heavy metals, and environmental chemicals accumulate in the body over time and can produce a wide range of symptoms, persistent fatigue, brain fog, joint pain, respiratory irritation, immune dysregulation, and neurological symptoms, that do not respond to conventional treatment because the underlying exposure has not been identified.
The clinical challenge is that these presentations closely mimic other conditions. A patient with mold toxicity may be evaluated for autoimmune disease, thyroid dysfunction, or depression before the environmental cause is considered. A patient with heavy metal accumulation may be told their symptoms are stress-related. Standard panels do not test for mycotoxins, specific heavy metals, or environmental chemicals, and most physicians are not trained to recognize or treat the clinical patterns they produce.
FFC is equipped to evaluate and manage toxin-related illness using specialty testing and physician-guided treatment protocols. It is one of a small number of practices in Monmouth County with this clinical focus.
What we commonly address
Mold toxicity and mycotoxin exposure affect a significant portion of the population, particularly in the Northeast where older building stock and moisture issues are common. Symptoms are diffuse and non-specific, which is what makes diagnosis so difficult in conventional settings. FFC uses mycotoxin urine panels from Mosaic Diagnostics and RealTime Labs to identify specific mold toxin exposures and guides patients through a structured detoxification and treatment protocol.
Heavy metal accumulation from arsenic, lead, mercury, and other environmental sources contributes to neurological symptoms, immune dysfunction, fatigue, and metabolic disruption. FFC evaluates heavy metal burden through specialty testing and addresses it as part of a comprehensive environmental health protocol.
Tick-borne illness including Lyme disease and its co-infections represents a distinct but related category of environmental exposure that standard testing frequently misses. FFC uses specialty panels through IGeneX and Galaxy Labs to screen for Lyme and co-infections beyond what standard antibody tests capture.
How FFC tests for toxin-related illness
Relevant testing includes mycotoxin urine panels through Mosaic Diagnostics and RealTime Labs, heavy metal profile, organic acids through the Metabolomix panel, HLA-DR genetic susceptibility testing, tick-borne illness panels through IGeneX and Galaxy Labs, comprehensive inflammatory markers, and immune function testing. Learn more about functional testing at FFC →
Where to start
Given the complexity and variability of toxin-related presentations, the Two-Step Assessment is the appropriate starting point for most patients in this category. It gives Dr. Boesler the full clinical picture before recommending a testing or treatment direction, and ensures that the right specialty panels are ordered for each patient's specific situation rather than a standard protocol. Learn more about the Two-Step Assessment →